Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative, Phase 4 Study

NCT01254721 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01254721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01254721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparison of the Effectiveness of Seroquel XR and Seroquel XR Plus Lithium in Patients With Acute Bipolar Mania: An Open-label, Randomized, Parallel Groups, Rater-blinded, 4 Week, Multicenter, Comparative, Phase 4 Study
Lead sponsor
AstraZeneca
Phase
Phase 4
Overall status
Terminated
Start date
December 31, 2010
Completion date
October 31, 2012
Enrollment
131 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

acute bipolar mania